International Medicine in Addiction Conference 2021 will take place online from the 26-28th of Feb.
This year’s theme of ‘Connecting the Disconnected’ acknowledges that doctors work with patients and communities who use substances that can cause complex issues, disconnection and marginalisation, and that they need to respond to people’s unique situations and issues.
This webinar will explore the impact of COVID-19 on access to addiction medicine and withdrawal options. More details to be released soon.
This event is part of the CCSA and CCDUS new webinar series on the Implications of COVID-19 on Public Health in Canada.
Dr. Ginette Poulin, Clinical Lead, Canadian Research Initiative in Substance Misuse
ASAM Level of Care Certification, the first program of its kind to independently assess and verify treatment programs’ ability to deliver services consistent with Levels of Care described in The ASAM Criteria®, launched on June 1st 2020. This session will give a brief overview of the certification and then provide an opportunity for attendees to ask detailed questions relative to the certification process.
The 21st Annual Conference of International Society of Addiction Medicine to be held in New Delhi, India from 13th to 16th November 2019.
The conference is being organised by the Department of Psychiatry & National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India.
The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center
Objective: In 2017, an academic health center in Chicago launched the multidisciplinary Substance Use Intervention Team (SUIT) to address opioid misuse across 18 inpatient units and in a new outpatient addiction medicine clinic. This report assesses the first 5 months of implementation and associations with patient health and healthcare utilization.
The 5th International Medicine in Addiction (IMiA) Conference will take place in Melbourne, 1st- 3rd March 2019.
The purpose of the Appropriate Use of Drug Testing in Clinical Addiction Medicine is to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction.
While substance use disorders (SUDs) are common, a standardised approach to addiction medicine training is less so.
This can lead to unsuitable treatment.